ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,258.61
-0.40%
Dow Jones
44,860.31
0.28%
Gold vs US Dollar
2,637.145
0.19%
Brent Oil
72.35
-0.14%
Bitcoin
92,708.42
0.80%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Aptose Biosciences Inc (APS) Share Price

APS Aptose Biosciences Inc

0.245
-0.015 (-5.77%)
26 Nov 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Aptose Biosciences Inc TSX:APS Toronto Stock Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.015 -5.77 0.245 0.245 0.265 0.27 0.245 0.27 50,986 20:59:56   
 Type  Size  Price  Time  Units 
  500 0.245 20:59:55 CAD
 
Recent News
DateTimeSource
HeadlineMore APS News
25/11/202421:15GLOBEAptose Biosciences Inc. Announces Closing of $8 Million Public Offering
22/11/202413:00GLOBEAptose Biosciences Inc. Announces Pricing of $8 Million Public Offering
20/11/202412:30GLOBEAptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
08/11/202421:01GLOBEAptose Reports Results for the Third Quarter 2024
05/09/202420:15GLOBEAptose Announces Results from Special Meeting of Shareholders
30/08/202420:30GLOBEAptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib
15/08/202420:30GLOBEAptose Announces Adjournment of its Special Meeting of Shareholders
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
26/09/201313:49PBBAlpha Strategic22
27/12/200623:11PBBAPS - new to AIM 11th Aug 200511
04/01/200501:19PBBAscribe.......... new to AIM2


Loading Follow Feed...

Latest Aptose Biosciences Inc Articles

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Level 2 Lite

1 year 35%, 2 years 45% and *3 years 60%

*Across 3 years £2132.64 only £853.06